Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
Bifendate (DDB) in Hepatoprotection: Applied Workflows & Tro
2026-07-08
Bifendate (DDB) stands out as a multifaceted hepatoprotection agent, excelling in both in vitro and in vivo research through its unique modulation of autophagy and lipid metabolism. This article translates high-impact multiomics insights into actionable protocols, troubleshooting strategies, and comparative guidance for experimental and translational scientists.
-
Tomivosertib Suppresses Ectopic Activity in Human DRG Neuron
2026-07-08
The referenced study provides direct evidence that tomivosertib, an MNK inhibitor, rapidly and reversibly suppresses pathological spontaneous activity in dorsal root ganglion neurons from patients with radiculopathy. This finding advances the translational neuroscience field by demonstrating a tangible therapeutic target and mechanism in human sensory neurons, with implications for neuropathic pain intervention.
-
CCR7–Notch1 Crosstalk Drives Stemness in Mammary Cancer Cell
2026-07-07
Boyle et al. (2017) established that direct signaling interplay between the chemokine receptor CCR7 and the Notch1 pathway sustains stem-like properties in mammary tumor cells, highlighting a dual regulatory mechanism in breast cancer stem cell maintenance. These findings suggest new therapeutic avenues for targeting tumor recurrence and therapy resistance.
-
3D Organoid-Fibroblast Co-cultures Model PDAC Chemoresistanc
2026-07-07
Schuth et al. present a patient-specific 3D organoid–fibroblast co-culture platform to dissect the stromal contributions to chemoresistance in pancreatic ductal adenocarcinoma. Their work demonstrates how cancer-associated fibroblasts drive tumor cell survival and epithelial-to-mesenchymal transition, offering a robust tool for personalized drug screening.
-
T0070907: Strategic PPARγ Antagonism for Translational Disco
2026-07-06
This article delivers an advanced perspective on T0070907, a nanomolar-potency PPARγ antagonist, as a transformative tool for mechanistic and translational research. By integrating recent insights into PPARγ/RXRα pathway modulation, cell cycle regulation, and inflammation—including links to senescence-associated secretory phenotypes (SASP) in atherosclerosis—the article presents strategic guidance for researchers aiming to dissect adipogenesis, cancer biology, and inflammatory aging. Protocol recommendations, competitive landscape analysis, and a critical outlook further distinguish this resource from standard product overviews.
-
Thiazovivin (A5506): Practical Guide for ROCK Inhibition in
2026-07-06
Thiazovivin is a highly pure ROCK inhibitor optimized for stem cell research applications such as induced pluripotent stem cell (iPSC) generation and human embryonic stem cell (hESC) survival. It addresses cell viability and reprogramming efficiency challenges, particularly during stressful manipulations like trypsinization. This reagent should not be used in diagnostic or medical settings, and its use is limited to well-controlled, scientific research workflows.
-
Irinotecan (CPT-11): Applied Workflows in Colorectal Cancer
2026-07-05
Irinotecan (CPT-11) is a benchmark topoisomerase I inhibitor, central to preclinical DNA damage and apoptosis research in colorectal cancer. This guide details advanced workflows, protocol enhancements, and troubleshooting strategies to maximize the reliability and translational value of Irinotecan-based studies.
-
Lysoptosis: Serpin-Regulated Lysosome-Dependent Cell Death R
2026-07-04
This study delineates lysoptosis as a distinct, evolutionarily conserved form of lysosome-dependent cell death (LDCD) defined by lysosomal membrane permeabilization and cathepsin release, occurring in the absence of intracellular serpin inhibitors. The findings clarify the mechanistic hierarchy and execution of regulated cell death, with direct implications for basic and translational research on apoptosis, neuroprotection, and cancer.
-
AICAR Empowers AMPK-Driven Inflammation Control & Metabolic
2026-07-03
AICAR (5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranoside) enables precise modulation of AMPK for advanced studies in energy metabolism and inflammation inhibition. This article dissects experimental workflows, in vitro and in vivo troubleshooting, and the reference study’s protocol innovations to maximize research impact using APExBIO’s AICAR.
-
1-myristoylglycerophosphocholine in Lipid Signaling Assays
2026-07-03
1-myristoylglycerophosphocholine (14:0 Lyso-PC) empowers researchers to precisely dissect lipid signaling dynamics in smooth muscle and fibrosis models. This guide translates recent breakthroughs in lysophospholipid metabolism into actionable workflows, troubleshooting strategies, and assay enhancements for advanced inflammation and membrane biology studies.
-
Dexamethasone (DHAP): Pathway Dissection and Model Optimizat
2026-07-02
Explore the scientific depth of Dexamethasone as a glucocorticoid anti-inflammatory agent. This article uniquely synthesizes mechanistic insights, advanced protocol parameters, and translational research value for optimizing neuroinflammation and stem cell models.
-
Self-Amplifying RNA Vaccines Enhance Influenza Immunogenicit
2026-07-02
This study systematically compared mRNA, self-amplifying RNA (saRNA), and circular RNA vaccine platforms for seasonal influenza, revealing that low-dose saRNA vaccines uniquely induce robust and durable immunity against influenza B and A subtypes. These findings highlight the promise of saRNA for dose-sparing, cross-subtype influenza vaccination and point to important considerations in RNA vaccine design.
-
Artesunate as a Precision Tool for Mechanistic Cancer Modeli
2026-07-01
Explore Artesunate, a potent artemisinin derivative, as a mechanistic probe in cancer research. This article uncovers how Artesunate enables advanced modeling of cell death pathways in vitro, bridging recent analytical innovations with practical assay design.
-
Neurotensin (CAS 39379-15-2): Next-Gen GPCR & miRNA Research
2026-07-01
Explore how Neurotensin, a potent Neurotensin receptor 1 activator, is transforming GPCR trafficking mechanism studies and miRNA regulation research. This article uniquely emphasizes spectral assay decisions and advanced applications in gastrointestinal physiology.
-
Sulfo-NHS-Biotin: Precision Protein Labeling for Cell Surfac
2026-06-30
Sulfo-NHS-Biotin enables highly selective, water-soluble labeling of cell surface proteins, optimizing workflows for affinity capture, immunoprecipitation, and interaction mapping. Its membrane-impermeant chemistry and robust protocol performance make it a gold standard for researchers seeking reproducibility and specificity in complex biological samples.